Table 1.
Case | First author [ref.] | Primary site | Treatment | Survival |
---|---|---|---|---|
1 | Alliot [3] | liver | – | 3 months |
2 | Bernathova [4] | breast | C (unknown), S | alive |
3 | Farid [2] | liver | C (liposomal doxorubicin) | 9 months |
4 | breast | C (liposomal doxorubicin, carboplatin, sirolimus, pazopanib, nab-paclitaxel, bevacizumab, and vinorelbine) | 11 months | |
5 | mediastinal | C (doxorubicin, paclitaxel, ifosfamide, cisplatin, gemcitabine, and vinorelbine) | 5 months | |
6 | heart | C (doxorubicin and ifosfamide) | 6 months | |
7 | breast | C (doxorubicin and ifosfamide) | 11 months | |
8 | skull, meninges | – | 1 month | |
9 | foot (bony) | – | 2 months | |
10 | Fujisawa [5] | spleen | C (docetaxel and paclitaxel) | alive |
11 | Habringer [6] | liver | – | – |
12 | Imafuku [7] | scalp | C (docetaxel), R | alive (>36 months) |
13 | Lespi [8] | liver | – | – |
14 | Maeda [9] | scalp | – | – |
15 | Massarweh [10] | scalp | – | – |
16 | Mazharuddin [11] | liver | – | – |
17 | Mazzocchi [12] | breast | S | 8 years |
18 | Moussa [13] | breast | – | – |
19 | Read [14] | scalp | C (paclitaxel, liposomal doxorubicin, gemcitabine, and vinorelbine) | – |
20 | Tan [15] | scalp | R | – |
21 | Tordjman [16] | liver or spleen | C (unknown) | 15 months |
22 | Wen [17] | scalp | – | – |
C, chemotherapy; S, surgery; R, radiation.